ロード中...
Ranitidine reduced levodopa-induced dyskinesia by remodeling neurochemical changes in hemiparkinsonian model of rats
BACKGROUND: Levodopa (l-dopa) remains the best drug in the treatment of Parkinson’s disease (PD). Unfortunately, long-term l-dopa caused motor complications, one of which is l-dopa-induced dyskinesia (LID). The precise mechanisms of LID are not fully understood. We have previously reported that rani...
保存先:
| 出版年: | Neuropsychiatr Dis Treat |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4455849/ https://ncbi.nlm.nih.gov/pubmed/26064051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S80174 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|